Related Experiment Videos
Retroviral proteins that target the major histocompatibility complex class I
Julie M Johnson1, Genoveffa Franchini
1National Cancer Institute, Basic Research Laboratory, 41/D804, Bethesda, MD 20892-5055, USA. johnsonjm@helix.nih.gov
Virus Research
|September 26, 2002
Summary
Human T-cell leukemia virus type 1 (HTLV-1) and human immunodeficiency virus type 1 (HIV-1) cause lifelong infections. This review focuses on how these retroviruses evade cytotoxic T-lymphocytes for immune evasion.
Area of Science:
- Virology
- Immunology
- Oncology
Background:
- Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia/lymphoma and tropical spastic paraparesis/HTLV-1-associated myelopathy.
- Human immunodeficiency virus type 1 (HIV-1) causes acquired immunodeficiency syndrome by killing CD4+ T-cells.
- Both HTLV-1 and HIV-1 are distinct human retroviruses that establish lifelong infections.
Purpose of the Study:
- To review the mechanisms by which HTLV-1 and HIV-1 evade host immune responses.
- To specifically examine viral evasion strategies targeting cytotoxic T-lymphocytes (CTLs).
Main Methods:
- This review synthesizes existing research on HTLV-1 and HIV-1 immune evasion.
- Focus is placed on the interaction between retroviruses and CTLs.
Main Results:
- HTLV-1 transforms T-cells and is linked to human cancers.
- HIV-1 leads to immune deficiency through CD4+ T-cell depletion.
- Both viruses have evolved mechanisms to escape CTL detection.
Conclusions:
- Understanding viral immune evasion is crucial for developing effective therapies.
- HTLV-1 and HIV-1 present unique challenges in controlling retroviral infections.
- Targeting CTL evasion mechanisms could be a key therapeutic strategy.